Details
- Autor(en) / Beteiligte
- Titel
- A unique aptamer-drug conjugate for targeted therapy of multiple myeloma
- Ist Teil von
- Leukemia, 2016-04, Vol.30 (4), p.987-991
- Ort / Verlag
- London: Nature Publishing Group UK
- Erscheinungsjahr
- 2016
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0887-6924eISSN: 1476-5551DOI: 10.1038/leu.2015.216Titel-ID: cdi_proquest_miscellaneous_1785237297
- Format
- –
- Schlagworte
- 13/106, 13/2, 13/31, 14, 14/34, 59, 59/5, 64/60, 692/308/2778, 692/699/1541/1990/804, 82, ADP-ribosyl Cyclase 1 - antagonists & inhibitors, ADP-ribosyl Cyclase 1 - genetics, ADP-ribosyl Cyclase 1 - metabolism, Animals, Antibody-drug conjugates, Apoptosis, Aptamers, Aptamers, Nucleotide - pharmacology, Blotting, Western, Cancer Research, Cell Proliferation, Critical Care Medicine, Development and progression, Drug Carriers, Drug Delivery Systems, Drug targeting, Drug therapy, Gene expression, Genetic aspects, Health aspects, Hematology, Humans, Innovations, Intensive, Internal Medicine, letter-to-the-editor, Medicine, Medicine & Public Health, Membrane Glycoproteins - antagonists & inhibitors, Membrane Glycoproteins - genetics, Membrane Glycoproteins - metabolism, Membrane proteins, Methods, Mice, Molecular targeted therapy, Multiple myeloma, Multiple Myeloma - genetics, Multiple Myeloma - pathology, Multiple Myeloma - therapy, Oncology, RNA, Small Interfering - genetics, Tumor Cells, Cultured, Xenograft Model Antitumor Assays